Dipeptidyl Peptidase-4 Inhibitor Alarms: Is Heart Failure Caused by a Class Effect?

被引：0
|
作者：
Lee, Yong-ho [1 ]
机构：
[1] Yonsei Univ, Coll Med, Severance Hosp, Div Endocrinol & Metab,Dept Internal Med, 50-1 Yonsei Ro, Seoul 120752, South Korea
来源：
DIABETES & METABOLISM JOURNAL | 2015年 / 39卷 / 03期
关键词：
SITAGLIPTIN; RISK; DESIGN; TRIAL;
D O I：
10.4093/dmj.2015.39.3.204
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：204 / 206
页数：3
相关论文
共 50 条
  • [31] Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans
    Ahren, B.
    Schweizer, A.
    Dejager, S.
    Villhauer, E. B.
    Dunning, B. E.
    Foley, J. E.
    DIABETES OBESITY & METABOLISM, 2011, 13 (09): : 775 - 783
  • [32] Severe edema and blood blisters of the lower extremities caused by sitagliptin, a dipeptidyl peptidase-4 inhibitor
    Maita, Hiroki
    Kobayashi, Tadashi
    Akimoto, Takashi
    Osawa, Hiroshi
    Kato, Hiroyuki
    JOURNAL OF GENERAL AND FAMILY MEDICINE, 2022, 23 (02): : 124 - 125
  • [33] Bullous pemphigoid associated with use of dipeptidyl peptidase-4 inhibitor
    Kano, Yasuhiro
    Kato, Miyuki
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (34) : E1186 - E1187
  • [34] Dipeptidyl peptidase-4 inhibitor-related renal disease
    Suenaga, Atsuhiko
    Sawa, Naoki
    Oba, Yuki
    Ikuma, Daisuke
    Sekine, Akinari
    Hasegawa, Eiko
    Mizuno, Hiroki
    Suwabe, Tatsuya
    Ikeda, Sara
    Tsujimoto, Tetsuro
    Kono, Kei
    Shintani-Domoto, Yukako
    Kinowaki, Keiichi
    Ohashi, Kenichi
    Miyazono, Motoaki
    Yamaguchi, Yutaka
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (10)
  • [35] Collagenous Colitis Possibly Associated with Dipeptidyl Peptidase-4 Inhibitor
    Takedomi, Hironobu
    Sakata, Yasuhisa
    Tomonaga, Michito
    Naruse, Naomi
    Yukimoto, Takahiro
    Akutagawa, Takashi
    Tsuruoka, Nanae
    Shimoda, Ryo
    Kido, Shinichi
    Esaki, Motohiro
    INTERNAL MEDICINE, 2022, 61 (18) : 2731 - 2734
  • [36] Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition
    Kirby, Mark
    Yu, Denise M. T.
    O'Connor, Stephen P.
    Gorrell, Mark D.
    CLINICAL SCIENCE, 2010, 118 (1-2) : 31 - 41
  • [37] Clinical Pharmacokinetics and Pharmacodynamics of Saxagliptin, a Dipeptidyl Peptidase-4 Inhibitor
    David W. Boulton
    Clinical Pharmacokinetics, 2017, 56 : 11 - 24
  • [38] Dipeptidyl peptidase-4 inhibitor for steroid-induced diabetes
    Yanai, Hidekatsu
    Masui, Yoshinori
    Yoshikawa, Reo
    Kunimatsu, Junwa
    Kaneko, Hiroshi
    WORLD JOURNAL OF DIABETES, 2010, 1 (03): : 99 - 100
  • [39] Dipeptidyl Peptidase-4 Inhibitors and Heart Failure Exacerbation in the Veteran Population: An Observational Study
    Cobretti, Michael R.
    Bowman, Benjamin
    Grabarczyk, Ted
    Potter, Emily
    PHARMACOTHERAPY, 2018, 38 (03): : 334 - 340
  • [40] Bullous pemphigoid associated with use of dipeptidyl peptidase-4 inhibitor
    Kano, Yasuhiro
    Kato, Miyuki
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (20) : E705 - E705
12345